Annual Working Capital
$3.61 M
-$4.30 M-54.35%
June 30, 2024
Summary
- As of February 7, 2025, NNVC annual working capital is $3.61 million, with the most recent change of -$4.30 million (-54.35%) on June 30, 2024.
- During the last 3 years, NNVC annual working capital has fallen by -$16.86 million (-82.36%).
- NNVC annual working capital is now -90.09% below its all-time high of $36.44 million, reached on June 30, 2014.
Performance
NNVC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$2.41 M
-$1.20 M-33.31%
September 1, 2024
Summary
- As of February 7, 2025, NNVC quarterly working capital is $2.41 million, with the most recent change of -$1.20 million (-33.31%) on September 1, 2024.
- Over the past year, NNVC quarterly working capital has dropped by -$293.80 thousand (-10.87%).
- NNVC quarterly working capital is now -94.10% below its all-time high of $40.85 million, reached on September 30, 2014.
Performance
NNVC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NNVC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.4% | -10.9% |
| 3 y3 years | -82.4% | -69.5% |
| 5 y5 years | +10000.0% | -69.5% |
NNVC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.4% | at low | -86.0% | at low |
| 5 y | 5-year | -82.4% | >+9999.0% | -89.2% | +194.6% |
| alltime | all time | -90.1% | +5572.3% | -94.1% | +194.6% |
NanoViricides Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.41 M(-33.3%) |
| Jun 2024 | $3.61 M(-54.3%) | $3.61 M(+33.6%) |
| Mar 2024 | - | $2.70 M(-38.1%) |
| Dec 2023 | - | $4.37 M(-29.5%) |
| Sep 2023 | - | $6.19 M(-21.7%) |
| Jun 2023 | $7.91 M(-43.5%) | $7.91 M(-17.4%) |
| Mar 2023 | - | $9.58 M(-13.6%) |
| Dec 2022 | - | $11.09 M(-12.2%) |
| Sep 2022 | - | $12.63 M(-9.8%) |
| Jun 2022 | $14.00 M(-31.6%) | $14.00 M(-10.0%) |
| Mar 2022 | - | $15.56 M(-9.4%) |
| Dec 2021 | - | $17.17 M(-9.7%) |
| Sep 2021 | - | $19.02 M(-7.1%) |
| Jun 2021 | $20.47 M(+73.1%) | $20.47 M(-8.4%) |
| Mar 2021 | - | $22.36 M(+23.2%) |
| Dec 2020 | - | $18.15 M(-10.0%) |
| Sep 2020 | - | $20.16 M(+70.4%) |
| Jun 2020 | $11.83 M(<-9900.0%) | $11.83 M(+180.0%) |
| Mar 2020 | - | $4.22 M(-265.8%) |
| Dec 2019 | - | -$2.55 M(+93.2%) |
| Sep 2019 | - | -$1.32 M(+5683.3%) |
| Jun 2019 | -$22.80 K(-100.4%) | -$22.80 K(-100.6%) |
| Mar 2019 | - | $3.55 M(+21.9%) |
| Dec 2018 | - | $2.91 M(-40.5%) |
| Sep 2018 | - | $4.89 M(-24.0%) |
| Jun 2018 | $6.44 M(-39.4%) | $6.44 M(-17.0%) |
| Mar 2018 | - | $7.76 M(+39.9%) |
| Dec 2017 | - | $5.55 M(-34.1%) |
| Sep 2017 | - | $8.42 M(-20.7%) |
| Jun 2017 | $10.62 M(-39.8%) | $10.62 M(-35.3%) |
| Mar 2017 | - | $16.41 M(+25.0%) |
| Dec 2016 | - | $13.13 M(-13.5%) |
| Sep 2016 | - | $15.18 M(-13.9%) |
| Jun 2016 | $17.64 M(-43.3%) | $17.64 M(-8.6%) |
| Mar 2016 | - | $19.29 M(-28.2%) |
| Dec 2015 | - | $26.88 M(-6.2%) |
| Sep 2015 | - | $28.66 M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | $31.08 M(-14.7%) | $31.08 M(-8.0%) |
| Mar 2015 | - | $33.77 M(-1.7%) |
| Dec 2014 | - | $34.37 M(-15.9%) |
| Sep 2014 | - | $40.85 M(+12.1%) |
| Jun 2014 | $36.44 M(+173.1%) | $36.44 M(+9.1%) |
| Mar 2014 | - | $33.40 M(+103.6%) |
| Dec 2013 | - | $16.40 M(-9.6%) |
| Sep 2013 | - | $18.14 M(+35.9%) |
| Jun 2013 | $13.34 M(+4.2%) | $13.34 M(+6.0%) |
| Mar 2013 | - | $12.59 M(-5.3%) |
| Dec 2012 | - | $13.28 M(+12.5%) |
| Sep 2012 | - | $11.81 M(-7.8%) |
| Jun 2012 | $12.81 M(+42.8%) | $12.81 M(+2.7%) |
| Mar 2012 | - | $12.48 M(+10.9%) |
| Dec 2011 | - | $11.25 M(+10.2%) |
| Sep 2011 | - | $10.21 M(+13.8%) |
| Jun 2011 | $8.97 M(+80.0%) | $8.97 M(+20.0%) |
| Mar 2011 | - | $7.48 M(-3.9%) |
| Dec 2010 | - | $7.78 M(+21.2%) |
| Sep 2010 | - | $6.42 M(+28.8%) |
| Jun 2010 | $4.98 M(+210.6%) | $4.98 M(+111.2%) |
| Mar 2010 | - | $2.36 M(-26.1%) |
| Dec 2009 | - | $3.19 M(-21.8%) |
| Sep 2009 | - | $4.08 M(+154.4%) |
| Jun 2009 | $1.60 M(+618.6%) | $1.60 M(+53.0%) |
| Mar 2009 | - | $1.05 M(-40.9%) |
| Dec 2008 | - | $1.77 M(-29.4%) |
| Sep 2008 | - | $2.51 M(+1025.5%) |
| Jun 2008 | $223.30 K(-40.4%) | $223.30 K(-81.6%) |
| Mar 2008 | - | $1.22 M(-39.0%) |
| Dec 2007 | - | $1.99 M(-10.0%) |
| Sep 2007 | - | $2.21 M(+490.6%) |
| Jun 2007 | $374.60 K(-82.5%) | $374.60 K(+261.6%) |
| Mar 2007 | - | $103.60 K(-88.8%) |
| Dec 2006 | - | $928.90 K(-41.7%) |
| Sep 2006 | - | $1.59 M(-25.8%) |
| Jun 2006 | $2.15 M(-3352.6%) | $2.15 M |
| Jun 2005 | -$66.00 K | - |
FAQ
- What is NanoViricides annual working capital?
- What is the all time high annual working capital for NanoViricides?
- What is NanoViricides annual working capital year-on-year change?
- What is NanoViricides quarterly working capital?
- What is the all time high quarterly working capital for NanoViricides?
- What is NanoViricides quarterly working capital year-on-year change?
What is NanoViricides annual working capital?
The current annual working capital of NNVC is $3.61 M
What is the all time high annual working capital for NanoViricides?
NanoViricides all-time high annual working capital is $36.44 M
What is NanoViricides annual working capital year-on-year change?
Over the past year, NNVC annual working capital has changed by -$4.30 M (-54.35%)
What is NanoViricides quarterly working capital?
The current quarterly working capital of NNVC is $2.41 M
What is the all time high quarterly working capital for NanoViricides?
NanoViricides all-time high quarterly working capital is $40.85 M
What is NanoViricides quarterly working capital year-on-year change?
Over the past year, NNVC quarterly working capital has changed by -$293.80 K (-10.87%)